Filament Health and ATMA Journey Centers Announce Licensing Agreement

Filament Health and ATMA Journey Centers Announce Licensing Agreement

Filament Health (FH) will license its natural psilocybin to ATMA Journey Centers for use in clinical trials, including an upcoming phase I trial on healthy subjects, which has already received Health Canada approval.

PDF of article